1. Home
  2. NEPH vs ECOR Comparison

NEPH vs ECOR Comparison

Compare NEPH & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • ECOR
  • Stock Information
  • Founded
  • NEPH 1997
  • ECOR 2005
  • Country
  • NEPH United States
  • ECOR United States
  • Employees
  • NEPH N/A
  • ECOR N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NEPH Health Care
  • ECOR Health Care
  • Exchange
  • NEPH Nasdaq
  • ECOR Nasdaq
  • Market Cap
  • NEPH 36.1M
  • ECOR 39.7M
  • IPO Year
  • NEPH 2004
  • ECOR 2018
  • Fundamental
  • Price
  • NEPH $3.65
  • ECOR $7.52
  • Analyst Decision
  • NEPH Buy
  • ECOR Strong Buy
  • Analyst Count
  • NEPH 1
  • ECOR 2
  • Target Price
  • NEPH $5.00
  • ECOR $25.50
  • AVG Volume (30 Days)
  • NEPH 51.5K
  • ECOR 126.8K
  • Earning Date
  • NEPH 08-07-2025
  • ECOR 08-06-2025
  • Dividend Yield
  • NEPH N/A
  • ECOR N/A
  • EPS Growth
  • NEPH N/A
  • ECOR N/A
  • EPS
  • NEPH 0.08
  • ECOR N/A
  • Revenue
  • NEPH $15,517,000.00
  • ECOR $26,458,000.00
  • Revenue This Year
  • NEPH $17.06
  • ECOR $23.21
  • Revenue Next Year
  • NEPH $12.20
  • ECOR $44.10
  • P/E Ratio
  • NEPH $49.00
  • ECOR N/A
  • Revenue Growth
  • NEPH 10.34
  • ECOR 41.54
  • 52 Week Low
  • NEPH $1.36
  • ECOR $4.47
  • 52 Week High
  • NEPH $5.00
  • ECOR $19.49
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 49.52
  • ECOR 61.13
  • Support Level
  • NEPH $3.45
  • ECOR $6.80
  • Resistance Level
  • NEPH $3.81
  • ECOR $7.80
  • Average True Range (ATR)
  • NEPH 0.26
  • ECOR 0.68
  • MACD
  • NEPH -0.10
  • ECOR 0.11
  • Stochastic Oscillator
  • NEPH 24.37
  • ECOR 62.11

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: